Last Updated: Friday, June 28, 2013, 19:35
Drug firm Novartis India Friday said its parent Novartis AG has offloaded 1.42 percent stake in it through open market for a consideration of over Rs 25 crore to meet market regulator SEBI guidelines.
Last Updated: Thursday, May 09, 2013, 15:09
Drug major Novartis India Thursday said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale to reduce stake in the Indian entity.
Last Updated: Monday, April 01, 2013, 15:09
Novartis, however, said: "This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options".
Last Updated: Monday, April 01, 2013, 09:27
Glivec, used in treating chronic myeloid leukemia and some other cancers, costs a patient about Rs 1.2 lakh/month, much higher than Rs 8,000 which is the price of the generic drug.
Last Updated: Thursday, March 28, 2013, 17:49
Shares of Novartis India on Wednesday closed higher by 3.75 percent, adding Rs 68 crore to its market capitalisation, after its Swiss-promoter said it intends to reduce stake in the Indian entity.
Last Updated: Thursday, March 28, 2013, 13:30
Novartis India on Thursday said it's Swiss-promoter Novartis AG intends to reduce its stake in the Indian entity to enable it to meet Sebi guidelines on the minimum public shareholding in the listed companies.
Last Updated: Tuesday, September 11, 2012, 20:45
The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.
more videos >>